Cardiff Oncology, Inc.

CRDFNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$593,000

▼ 13.2% YoY

Net Income

-$45.9M

▼ 0.9% YoY

EPS

$-0.69

▲ 27.4% YoY

Cash

$17.5M

▼ 66.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.